[#item_full_content] A federal health agency has published a new report on recent advances in psychedelic medicine, along with recommendations for state policymakers on how to prepare for formal approval of drugs like psilocybin and MDMA. It also notes how the Schedule I status of many psychedelics has hampered scientific studies on their effects for decades. “Psychedelic-assisted 
Read More
States Should Start Planning Now For FDA Approval Of Psychedelics, Federal Report Says
ByPot Shop News
August 26, 2026